Business Description
Starpharma is an Australian biopharmaceutical company founded in 1997 that develops and sells products built on its proprietary dendrimer technology, a versatile platform used to improve how drugs are delivered in the body. Its consumer-facing products include a vaginal gel for bacterial infections, an antiviral nasal spray, and an antiviral condom coating. The company is also advancing several cancer treatments through clinical trials, using its dendrimer technology to target tumors more precisely and reduce side effects. In addition, Starpharma is working with investment firm Medicxi to develop a new cancer therapy called Petalion Therapeutics.
